QED might interfere and treat RA through lipid and atherosclerosis, cancer pathways, PI3K-Akt, AGE-RAGE, IL-17, TNF, as well as HIF-1 signaling pathways. The gene discussed is RENBP; the disease is rheumatoid arthritis.